Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Sep. 27, 2014	Sep. 28, 2013	Sep. 29, 2012
Cash flows from operating activities:
Net income	$ 597,414	$ 484,103	$ 363,500
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization of fixed assets	214,607	183,814	135,656
Amortization of intangibles	43,032	45,379	45,991
Amortization of deferred financing fees	5,651	7,125	6,050
Unrealized loss (gain) on foreign currency, net	15,196	9,159	(6,557)
(Gain) loss on disposal of fixed assets	(602)	(85)	2,517
Gain on sale of subsidiary, excluding transaction costs			(28,914)
Provision for doubtful accounts	1,782	689	3,197
Provision for sales returns	114,057	79,747	107,436
(Gain) loss on derivatives, net	(1,582)	(4,507)	6,310
Excess tax benefits from equity-based compensation plans	(55,444)	(54,699)	(12,070)
Deferred income taxes	(52,708)	(17,701)	60,856
Deferred compensation and stock compensation	30,882	26,315	18,079
Other	4,826	844	(672)
Changes in assets and liabilities
Receivables	(274,884)	(187,221)	(159,317)
Inventories	(166,473)	87,677	(92,862)
Income tax payable/receivable, net	120,553	46,290	16,457
Other current assets	(838)	(12,668)	(6,900)
Other long-term assets, net	3,162	3,915	(469)
Accounts payable and accrued expenses	133,818	133,532	17,125
Other current liabilities	(7,521)	3,100	(2,718)
Other long-term liabilities	(5,495)	1,161	5,090
Net cash provided by operating activities	719,433	835,969	477,785
Cash flows from investing activities:
Change in restricted cash	182	3,005	(2,875)
Purchase of short-term investments	(100,000)
Purchase of long-term investment	(35,905)
Proceeds from the sale of subsidiary, net of cash acquired			137,733
Capital expenditures for fixed assets	(337,860)	(232,780)	(401,121)
Other investing activities	1,164	4,208	618
Net cash used in investing activities	(472,419)	(225,567)	(265,645)
Cash flows from financing activities:
Net change in revolving line of credit		(226,210)	(108,727)
Proceeds from issuance of common stock under compensation plans	40,681	29,777	12,092
Proceeds from issuance of common stock for private placement	1,348,414
Repurchase of common stock	(1,052,430)	(188,278)	(76,470)
Excess tax benefits from equity-based compensation plans	55,444	54,699	12,070
Payments on capital lease and financing obligations	(1,931)	(8,288)	(7,558)
Proceeds from borrowings of long-term debt	403
Repayment of long-term debt	(13,361)	(71,620)	(7,814)
Dividends paid	(118,358)
Purchase of noncontrolling interest	(4,752)
Other financing activities	(1,124)	(1,406)	3,283
Net cash provided by (used in) financing activities	252,986	(411,326)	(173,124)
Change in cash balances included in current assets held for sale			5,160
Effect of exchange rate changes on cash and cash equivalents	1,122	2,727	1,124
Net increase in cash and cash equivalents	501,122	201,803	45,300
Cash and cash equivalents at beginning of period	260,092	58,289	12,989
Cash and cash equivalents at end of period	761,214	260,092	58,289
Supplemental disclosures of cash flow information:
Cash paid for interest	12,043	9,129	20,783
Cash paid for income taxes	270,367	223,580	136,407
Dividends declared not paid at the end of each period	40,580
Fixed asset purchases included in accounts payable and not disbursed at the end of each period	64,202	30,541	56,127
Noncash investing and financing activities:
Fixed assets acquired under capital lease and financing obligations	40,125	27,791	66,531
Settlement of acquisition related liabilities through release of restricted cash		$ 9,227	$ 18,788